Skip to main content

Peer Review reports

From: Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer

Original Submission
15 Mar 2021 Submitted Original manuscript
23 Mar 2021 Author responded Author comments - Norikazu Masuda
Resubmission - Version 2
23 Mar 2021 Submitted Manuscript version 2
22 May 2021 Reviewed Reviewer Report
1 Jun 2021 Reviewed Reviewer Report
16 Jul 2021 Author responded Author comments - Norikazu Masuda
Resubmission - Version 3
16 Jul 2021 Submitted Manuscript version 3
31 Jul 2021 Reviewed Reviewer Report
15 Aug 2021 Reviewed Reviewer Report
6 Sep 2021 Author responded Author comments - Norikazu Masuda
Resubmission - Version 4
6 Sep 2021 Submitted Manuscript version 4
2 Oct 2021 Reviewed Reviewer Report
14 Oct 2021 Reviewed Reviewer Report
5 Nov 2021 Author responded Author comments - Norikazu Masuda
Resubmission - Version 5
5 Nov 2021 Submitted Manuscript version 5
Publishing
5 Nov 2021 Editorially accepted
24 Nov 2021 Article published 10.1186/s12885-021-08973-4

You can find further information about peer review here.

Back to article page